Cargando…

Elevated Levels of Lewis Y and Integrin α(5)β(1) Correlate with Chemotherapeutic Drug Resistance in Epithelial Ovarian Carcinoma

OBJECTIVE: To measure Lewis y and integrin α(5)β(1) expression in epithelial ovarian carcinoma and to correlate the levels of these molecules with ovarian carcinoma chemotherapy and prognosis. METHODS: The study population included 34 ovarian carcinoma patients with chemotherapeutic drug-resistance,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Zhenhua, Gao, Song, Gao, Jian, Hou, Rui, Liu, Chuan, Liu, Juanjuan, Li, Beibei, Liu, Dawo, Zhang, Shulan, Lin, Bei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546651/ https://www.ncbi.nlm.nih.gov/pubmed/23443083 http://dx.doi.org/10.3390/ijms131215588

Ejemplares similares

Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance
por: Gao, Jian, et al.
Publicado: (2013)

High Expression of Lewis y Antigen and CD44 Is Correlated with Resistance to Chemotherapy in Epithelial Ovarian Cancers
por: Hu, Zhenhua, et al.
Publicado: (2013)

Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression
por: Hou, Rui, et al.
Publicado: (2017)

Co-Expression of Lewis y Antigen with Human Epididymis Protein 4 in Ovarian Epithelial Carcinoma
por: Zhuang, Huiyu, et al.
Publicado: (2013)

Study on the Expression and Clinical Significances of Lewis y Antigen and Integrin αv, β3 in Epithelial Ovarian Tumors
por: Wang, Yifei, et al.
Publicado: (2011)

The Stimulation of IGF-1R Expression by Lewis(y) Antigen Provides a Powerful Development Mechanism of Epithelial Ovarian Carcinoma
por: Liu, Dawo, et al.
Publicado: (2011)

Lewis y Regulate Cell Cycle Related Factors in Ovarian Carcinoma Cell RMG-I in Vitro via ERK and Akt Signaling Pathways
por: Liu, Dawo, et al.
Publicado: (2012)

Chemoresistance Is Associated with MUC1 and Lewis y Antigen Expression in Ovarian Epithelial Cancers
por: Zhang, Danye, et al.
Publicado: (2013)

c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer
por: Hao, Yingying, et al.
Publicado: (2017)

Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway
por: Liu, Juanjuan, et al.
Publicado: (2009)

Beclin 1 Expression in Ovarian Tissues and Its Effects on Ovarian Cancer Prognosis
por: Cai, Mingbo, et al.
Publicado: (2014)

Lewis y antigen promotes p27 degradation by regulating ubiquitin-proteasome activity
por: Cai, Mingbo, et al.
Publicado: (2017)

Autophagy-independent enhancing effects of Beclin 1 on cytotoxicity of ovarian cancer cells mediated by proteasome inhibitors
por: Liu, Chuan, et al.
Publicado: (2012)

Co-expression of Lewis y antigen and CD147 in epithelial ovarian cancer is correlated with malignant progression and poor prognosis
por: Liu, Juanjuan, et al.
Publicado: (2019)

Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells
por: Zhuang, Huiyu, et al.
Publicado: (2014)

Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I
por: Gao, Lili, et al.
Publicado: (2011)

Lewis (y) Antigen Overexpression Increases the Expression of MMP-2 and MMP-9 and Invasion of Human Ovarian Cancer Cells
por: Yan, Limei, et al.
Publicado: (2010)

Increase in Docetaxel-Resistance of Ovarian Carcinoma-Derived RMG-1 Cells with Enhanced Expression of Lewis Y Antigen
por: Zhang, Fan, et al.
Publicado: (2011)

Lewis Y Promotes Growth and Adhesion of Ovarian Carcinoma-Derived RMG-I Cells by Upregulating Growth Factors
por: Li, Feifei, et al.
Publicado: (2010)

Gene expression profile analysis identifies metastasis and chemoresistance-associated genes in epithelial ovarian carcinoma cells
por: Zhu, Liancheng, et al.
Publicado: (2014)

The fucosylated CD147 enhances the autophagy in epithelial ovarian cancer cells
por: Hu, Zhenhua, et al.
Publicado: (2016)

Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma
por: WANG, SHENG-TAN, et al.
Publicado: (2011)

Integrin Targeted Delivery of Chemotherapeutics
por: Chen, Kai, et al.
Publicado: (2011)

HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect
por: Liu, Duanyang, et al.
Publicado: (2018)

Interaction of CD147 and human epididymis protein 4 promotes invasion and metastasis of ovarian cancer
por: Gao, Lingling, et al.
Publicado: (2021)

The Effects of Chemotherapeutics on the Ovarian Cancer Microenvironment
por: Eckert, Mark A., et al.
Publicado: (2021)

Tripterygium glycosides sensitizes cisplatin chemotherapeutic potency by modulating gut microbiota in epithelial ovarian cancer
por: Zhan, Xinlu, et al.
Publicado: (2023)

αV-Integrins Are Required for Mechanotransduction in MDCK Epithelial Cells
por: Teräväinen, Terhi P., et al.
Publicado: (2013)

Promotion of Bone Lesions Through the Myeloma Integrin α6-Mediated Osteolytic Signaling
por: Liu, Huan, et al.
Publicado: (2021)

Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells
por: Roggiani, Francesca, et al.
Publicado: (2016)

Lewis Y regulates signaling molecules of the transforming growth factor β pathway in ovarian carcinoma-derived RMG-I cells
por: LI, FEI-FEI, et al.
Publicado: (2011)

Identification of key genes for guiding chemotherapeutic management in ovarian cancer using translational bioinformatics
por: Yuan, Danni, et al.
Publicado: (2020)

Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells
por: Wang, Jing, et al.
Publicado: (2019)

PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells
por: Liu, Hao, et al.
Publicado: (2013)

HERPUD1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K/AKT/mTOR and p38 MAPK signaling pathways
por: Nie, Xin, et al.
Publicado: (2022)

Integrin α(E)(CD103)β(7) in Epithelial Cancer
por: Hoffmann, Johanna C., et al.
Publicado: (2021)

The Roles of Integrin α5β1 in Human Cancer
por: Hou, Jianbing, et al.
Publicado: (2020)

Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer
por: Li, Xiaoguang, et al.
Publicado: (2016)

Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer
por: Gou, Rui, et al.
Publicado: (2022)

Dickkopf-4 is frequently overexpressed in epithelial ovarian carcinoma and promotes tumor invasion
por: Wang, Shizhuo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vqo47nijs4ag68clob6b4nnc42